Patents by Inventor Wolfgang Weglöhner

Wolfgang Weglöhner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8691512
    Abstract: Uses of recombinant procalcitonin 3-116 in the diagnosis and therapy of septic diseases and the measurement of prohormones other than procalcitonin, and of dipeptidyl peptidase IV, as biomarkers in the diagnosis of sepsis.
    Type: Grant
    Filed: April 8, 2010
    Date of Patent: April 8, 2014
    Assignee: B.R.A.H.M.S. GmbH
    Inventors: Andreas Bergmann, Joachim Struck, Wolfgang Weglöhner
  • Patent number: 7998686
    Abstract: Uses of recombinant procalcitonin 3-116 in the diagnosis and therapy of septic diseases and the measurement of prohormones other than procalcitonin, and of dipeptidyl peptidase IV, as biomarkers in the diagnosis of sepsis.
    Type: Grant
    Filed: September 29, 2008
    Date of Patent: August 16, 2011
    Assignee: B.R.A.H.M.S. GmbH
    Inventors: Andreas Bergmann, Joachim Struck, Wolfgang Weglöhner
  • Patent number: 7972799
    Abstract: Uses of recombinant procalcitonin 3-116 in the diagnosis and therapy of septic diseases and the measurement of prohormones other than procalcitonin, and of dipeptidyl peptidase IV, as biomarkers in the diagnosis of sepsis.
    Type: Grant
    Filed: February 18, 2009
    Date of Patent: July 5, 2011
    Assignee: B.R.A.H.M.S. GmbH
    Inventors: Andreas Bergmann, Joachim Struck, Wolfgang Weglöhner
  • Publication number: 20110008812
    Abstract: Uses of recombinant procalcitonin 3-116 in the diagnosis and therapy of septic diseases and the measurement of prohormones other than procalcitonin, and of dipeptidyl peptidase IV, as biomarkers in the diagnosis of sepsis.
    Type: Application
    Filed: April 8, 2010
    Publication date: January 13, 2011
    Inventors: Andreas BERGMANN, Joachim Struck, Wolfgang Weglöhner
  • Patent number: 7723492
    Abstract: Uses of recombinant procalcitonin 3-116 in the diagnosis and therapy of septic diseases and the measurement of prohormones other than procalcitonin, and of dipeptidyl peptidase IV, as biomarkers in the diagnosis of sepsis.
    Type: Grant
    Filed: September 29, 2008
    Date of Patent: May 25, 2010
    Assignee: B.R.A.H.M.S. Aktiengesellschaft
    Inventors: Andreas Bergmann, Joachim Struck, Wolfgang Weglöhner
  • Patent number: 7498139
    Abstract: Uses of recombinant procalcitonin 3-116 in the diagnosis and therapy of septic diseases and the measurement of prohormones other than procalcitonin, and of dipeptidyl peptidase IV, as biomarkers in the diagnosis of sepsis.
    Type: Grant
    Filed: March 25, 2004
    Date of Patent: March 3, 2009
    Assignee: B.R.A.H.M.S. Aktiengesellschaft
    Inventors: Andreas Bergmann, Joachim Struck, Wolfgang Weglöhner
  • Patent number: 7015003
    Abstract: Improved receptor assays for the detection of thyroid stimulating hormone receptor (TSHR) autoantibodies are described which use immobilized, affinity-purified rTSHR preparations as specific binders. This format, as well as novel measures for neutralizing pathologically increased human TSH (hTSH) levels in the sera, e.g., by the addition of anti-hHSH antibody, and/or eliminating the influence of anti-bovine TSH antibody, result in increased assay reliability and open up the possibility of preparing the assay constituents in a ready to use and/or well-standardized form for automatic processing and/or convenient marketing.
    Type: Grant
    Filed: January 13, 1999
    Date of Patent: March 21, 2006
    Assignee: B.R.A.H.M.S Aktiengesellschaft
    Inventors: Andreas Bergmann, Joachim Struck, Nils Morgenthaler, Wolfgang Weglöhner, Jörg-Michael Hollidt
  • Patent number: 6756483
    Abstract: Uses of recombinant procalcitonin 3-116 in the diagnosis and therapy of septic diseases and the measurement of prohormones other than procalcitonin, and of dipeptidyl peptidase IV, as biomarkers in the diagnosis of sepsis.
    Type: Grant
    Filed: May 29, 2001
    Date of Patent: June 29, 2004
    Assignee: B.R.A.H.M.S Aktiengesellschaft
    Inventors: Andreas Bergmann, Joachim Struck, Wolfgang Weglöhner